FOOD SCIENCE ›› 2026, Vol. 47 ›› Issue (20): 394-404.doi: 10.7506/spkx1002-6630-20260417-169

• Reviews • Previous Articles    

Research Progress on Immune Epitope Basis and Molecular Mechanisms of Oral Tolerance Induced by Undenatured Type II Collagen

WANG Peng, WANG Chunlong, QI Xinyuan, ZHAO Zifang,, WU Haohao   

  1. 1. College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China; 2. Fipharm (Group) Co. Ltd., Haikou 570100, China; 3. Hainan/Haikou Research & Development Center for Biopeptide Engineering, Hainan Huayan Collagen Technology Co. Ltd., Haikou 570100, China
  • Published:2026-11-06

Abstract: Rheumatoid arthritis (RA) is an autoimmune disease whose core pathological mechanism lies in the loss of self-tolerance of the immune system to type II collagen (CII), the major component of articular cartilage. Oral tolerance, a physiological strategy that restores antigen-specific immune tolerance, provides a unique therapeutic window for the intervention of such diseases. This review systematically explores the immune epitope basis, molecular mechanisms, and systemic immunoregulatory network involved in oral immune tolerance induced by undenatured type II collagen (UC-II). 收稿日期:2026-04-17 基金项目:海南省重点研发项目(ZDYF2026XDNY141) 第一作者简介:王朋(2001—)(ORCID: 0009-0002-5017-5274),男,博士研究生,研究方向为水产品高值化利用。 E-mail: wangpeng83668@163.com *通信作者简介:赵子方(1987—)(ORCID: 0009-0006-3291-6920),男,高级工程师,博士,研究方向为生物活性肽。 E-mail: 290638921@qq.com 吴浩浩(1987—)(ORCID: 0000-0003-3852-2608),男,教授,博士,研究方向为水产品高值化利用。 E-mail: wuhaohao@ouc.edu.cn Current evidence indicates that the immunomodulatory efficacy of UC-II highly depends on the integrity of its native triple helical structure. This conformation not only protects key antigenic determinants from gastrointestinal degradation but also ensures that the specifically glycosylated immunodominant epitope (CII 256–270) is completely taken up by gut-associated lymphoid tissue. The core of this epitope recognition lies in the galactosylation of lysine at position 264 (Gal-Hyl264), which acts as a crucial molecular code for precise recognition and tolerance initiation by T cell receptors. Mechanistically, CD103+ dendritic cells within gut-associated lymphoid tissue present this glycopeptide antigen and, in a microenvironment enriched with retinoic acid and transforming growth factor-β (TGF-β), efficiently induce the differentiation of antigen-specific Foxp3+ regulatory T cells (Tregs). Subsequently, these Tregs undergo homing receptor reprogramming (shifting from gut-specific CCR9/α4β7 to inflammation-chemotactic CCR6/CCR4) enabling their precise migration from the intestine to inflamed joint tissues. Ultimately, within the local joint environment, activated Tregs exert bystander suppression by secreting inhibitory cytokines such as interleukin-10 and TGF-β, thereby blocking multiple inflammatory cascades and mitigating cartilage damage. By synthesizing recent advances in structural biology, immunology, as well as preclinical and clinical studies, this review systematically elucidates the scientific connotation of UC-II as a precision immunomodulator, aiming to provide robust theoretical support for developing oral tolerance-based therapeutic strategies for autoimmune and degenerative joint diseases.

Key words: undenatured type II collagen; oral tolerance; type II collagen immune epitope; glycosylation; regulatory T cells;

CLC Number: